Literature DB >> 2123975

Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses.

M L Collins1, E I Traboulsi, I H Maumenee.   

Abstract

The ocular findings in 108 patients representative of all types of mucopolysaccharidoses (MPS) were reviewed. Attention was focused on optic nerve head appearance. Optic nerve head swelling was observed in 8/14 eyes of MPS 1-Hurler (MPS 1-H); 9/21 MPS 1-Hurler-Scheie (MPS 1-H-S); 0/4 MPS I-S; 13/66 MPS II; 1/22 MPS III; 0/58 MPS IV; 5/12 MPS VI; and 2/2 MPS VII eyes. In three patients, optic nerve head swelling was present in one eye and optic atrophy in the fellow eye; in four patients, optic atrophy followed disc elevation; three patients presented with bilateral optic atrophy. It was concluded that optic nerve head swelling precedes the development of optic atrophy in the systemic MPS.

Entities:  

Mesh:

Year:  1990        PMID: 2123975     DOI: 10.1016/s0161-6420(90)32400-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI.

Authors:  Reinhard G Schumacher; Rita Brzezinska; Gudrun Schulze-Frenking; Susanne Pitz
Journal:  Pediatr Radiol       Date:  2008-02-26

2.  [Diffuse stromal corneal opacity and alterations of the hands].

Authors:  I M Lanzl; S-F Seidova; A Erben; K Thürmel; K Kotliar
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

Review 3.  Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?

Authors:  Amauri Dalla Corte; Carolina F M de Souza; Maurício Anés; Roberto Giugliani
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

Review 4.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

Review 5.  Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed.

Authors:  S Al Sawaf; E Mayatepek; B Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-07-13       Impact factor: 4.982

6.  Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Authors:  Susanne Pitz; Olufunmilola Ogun; Laila Arash; Elke Miebach; Michael Beck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-22       Impact factor: 3.117

7.  Visual Dysfunction of Type I and VI Mucopolysaccharidosis Patients Evaluated with Visual Evoked Cortical Potential.

Authors:  Bruno Duarte Gomes; Givago da Silva Souza; Gustavo Monteiro Viana; Isabel Cristina Neves de Souza; Patricia do Socorro Queiroz Feio; Ida Vanessa Doederlein Schwartz; Diane Ruschel Marinho; Manoel da Silva Filho; Roberto Giugliani; Luiz Carlos de Lima Silveira; Luiz Carlos Santana da Silva
Journal:  Case Rep Ophthalmol       Date:  2012-03-26

8.  Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.

Authors:  Maurizio Scarpa; Zsuzsanna Almássy; Michael Beck; Olaf Bodamer; Iain A Bruce; Linda De Meirleir; Nathalie Guffon; Encarna Guillén-Navarro; Pauline Hensman; Simon Jones; Wolfgang Kamin; Christoph Kampmann; Christina Lampe; Christine A Lavery; Elisa Leão Teles; Bianca Link; Allan M Lund; Gunilla Malm; Susanne Pitz; Michael Rothera; Catherine Stewart; Anna Tylki-Szymańska; Ans van der Ploeg; Robert Walker; Jiri Zeman; James E Wraith
Journal:  Orphanet J Rare Dis       Date:  2011-11-07       Impact factor: 4.123

Review 9.  Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.

Authors:  Carlton R Fenzl; Kyla Teramoto; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2015-09-07

10.  Growth charts for patients with Hunter syndrome.

Authors:  Pravin Patel; Yasuyuki Suzuki; Miho Maeda; Eriko Yasuda; Tsutomu Shimada; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab Rep       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.